M. Toth et T. Shenk, ANTAGONIST-MEDIATED DOWN-REGULATION OF 5-HYDROXYTRYPTAMINE TYPE-2 RECEPTOR GENE-EXPRESSION - MODULATION OF TRANSCRIPTION, Molecular pharmacology, 45(6), 1994, pp. 1095-1100
Prolonged exposure to an agonist results in a progressive loss of most
G protein-coupled receptors, whereas exposure to an antagonist causes
increased receptor response. The 5-hydroxy-tryptamine (5-HT)(2) recep
tor is down-regulated by agonists but, paradoxically, antagonists can
also elicit a decrease in receptor density. Here we show that long ter
m treatment with serotonin or mianserin, an antagonist and antidepress
ant, results in reduced levels of both the 5-HT2 receptor and its RNA.
Antagonist-induced down-regulation requires the presence of the 5-HT2
receptor, it occurs at the level of transcription, and it is mediated
by a drug response sequence in the 5' flanking region of the 5-HT2 re
ceptor gene. The effect of mianserin might result, at least in part, f
rom its ability to modulate transcription.